ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Catapult Receives FDA Clearance of IND for Humanized Anti-CCR7 Antibody americanpharmaceuticalreview
February 22, 2021Catapult Therapeutics has announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for its lead product candidate CAP-100, an innovative first-in-class humanized anti-CCR7 antibody for treatment ...
Pharma Sources Insight January 2025
